Win tickets to Evergreen State Fair concert
The Herald of Everett, Washington
Customer service  |  Subscribe   |   Log in or sign up   |   Advertising information   |   Contact us
HeraldNet on Facebook HeraldNet on Twitter HeraldNet RSS feeds HeraldNet Pinterest HeraldNet Google Plus HeraldNet Youtube
HeraldNet Newsletters  Newsletters: Sign up  Green editions icon Green editions

FDA warns of allergic reactions to acne products

SHARE: facebook Twitter icon Linkedin icon Google+ icon Email icon |  PRINTER-FRIENDLY  |  COMMENTS
Associated Press
Published:
WASHINGTON — Federal health officials are warning consumers who use popular anti-acne treatments about rare but potentially deadly allergic reactions that can cause swelling of the face and difficulty breathing.
The Food and Drug Administration said Wednesday the problems have been reported with gels, face washes, pads and other products that contain two ingredients: benzoyl peroxide or salicylic acid. But the agency says it’s unclear whether those ingredients trigger the reactions or whether some other combination of ingredients is to blame.
The over-the-counter treatments are sold as Proactiv, Neutrogena, MaxClarity, Oxy, Aveeno and other brands.
For now the agency wants consumers to stop using the products immediately if they experience tightness of the throat, breathing problems, lightheadedness or swelling of the eyes, face or lips. Users can test their sensitivity to a new treatment by dabbing a small amount on their skin for three days. If they don’t experience a reaction the product can generally be used safely as directed.
An FDA analysis uncovered 131 reports of serious allergic reactions with topical acne drugs over the last 44 years. None of the cases were fatal, but 44 percent of people had to be hospitalized. Most of the problems emerged within 24 hours of first using the treatment.
Regulators stressed that these hypersensitivity reactions are much more serious than rashes and irritations often seen with skin products.
Story tags » Health

More Nation & World Headlines

NEWSLETTER

HeraldNet Headlines

Top stories and breaking news updates

Calendar

Share your comments: Log in using your HeraldNet account or your Facebook, Twitter or Disqus profile. Comments that violate the rules are subject to removal. Please see our terms of use. Please note that you must verify your email address for your comments to appear.

You are logged in using your HeraldNet ID. Click here to update your profile. | Log out.

Our new comment system is not supported in IE 7. Please upgrade your browser here.

comments powered by Disqus